Dermatological adverse events during hematological and oncological therapies (Bruton's tyrosine kinase inhibitors and mogamulizumab): an Italian retrospective multicenter study

dAEs are common but manageable side effects of BTKIs and mogamulizumab. Dermatologic surveillance and early treatment are crucial for optimizing patient outcomes. Multidisciplinary collaboration is essential to prevent misdiagnosis and treatment interruptions, especially in cases of mogamulizumab-associated rash.

Authors

Institutions

Publication Details

Journal
Italian Journal of Dermatology and Venereology
Published
2025-10-01
DOI
https://doi.org/10.23736/s2784-8671.25.08294-5
Primary Topic
Cutaneous lymphoproliferative disorders research
Type
article
Field-Weighted Citation Impact
0.00
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

Dermatological adverse events during hematological and oncological therapies (Bruton's tyrosine kinase inhibitors and mogamulizumab): an Italian retrospective multicenter study

Martina D’Onghia, Luca Rapparini, Simone Ribero, Giovanni Paolino et al.
Italian Journal of Dermatology and Venereology
Cutaneous lymphoproliferative disorders research
article

Dermatological adverse events during hematological and oncological therapies (Bruton's tyrosine kinase inhibitors and mogamulizumab): an Italian retrospective multicenter study

Martina D’Onghia, Luca Rapparini, Simone Ribero, Giovanni Paolino, Giulio Gualdi, Corrado Zengarini, Martina Merli, Alessandro Pileri, Laura Calabrese, Bianca Maria Piraccini, Paola Vitiello, Stephano Cedirian, Pietro Sollena, Davide Fattore, Fabio Lobefaro, Élisa Cinotti, Ilaria Proietti, Pietro Quaglino, Franco Rongioletti, Michela Valeria Rita Starace, L Gandolfi, Elisabetta Fulgione
article en

Abstract

dAEs are common but manageable side effects of BTKIs and mogamulizumab. Dermatologic surveillance and early treatment are crucial for optimizing patient outcomes. Multidisciplinary collaboration is essential to prevent misdiagnosis and treatment interruptions, especially in cases of mogamulizumab-associated rash.

Italian Journal of Dermatology and VenereologyVol. 160(5)
University of Siena (IT), Vita-Salute San Raffaele University (IT), University of Campania "Luigi Vanvitelli" (IT), Agostino Gemelli University Polyclinic (IT), University of Chieti-Pescara (IT), Azienda USL di Bologna (IT), University of the Sacred Heart (JP), University of Turin (IT), University of Naples Federico II (IT), Sapienza University of Rome (IT), University of Bologna (IT)
Openalex Percentile: Top 52%
Cutaneous lymphoproliferative disorders research
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.